首页> 外文会议>the European Peptide Symposium >CHIMERIC MULTIFUNCTIONAL LIGANDS FOR THE TREATMENT OF PAIN
【24h】

CHIMERIC MULTIFUNCTIONAL LIGANDS FOR THE TREATMENT OF PAIN

机译:用于治疗疼痛的嵌合多功能配体

获取原文

摘要

Cholecystokinin (CCK) is known to give an anti-opioid effect and as a result, causes an increase of pain by inhibiting the opioid response. Recent research has shown further that melanocortin (MC) receptors, mainly subtype MC-4R, produce an increase in response to pain stimuli. Based on this previous work, we are developing chimeric ligands which will be of benefit to therapeutic pain treatment with enhanced opioid efficacy by acting as agonists at opioid receptors and antagonists at both CCK and MC receptors .
机译:已知胆囊蛋白(CCK)得到抗阿片类药物,因此通过抑制阿片类药物反应导致疼痛的增加。最近的研究进一步显示了Melanocortin(MC)受体,主要是亚型MC-4R,产生对疼痛刺激的反应增加。基于此前一项工作,我们正在开发嵌合配体,其将有益于治疗疼痛治疗,其通过作为阿片类受体的激动剂和在CCK和MC受体的拮抗剂中作为激动剂而具有增强的阿片类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号